Oct 30 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC: AURA BIOSCIENCES REPORTS POSITIVE
PHASE
1B/2 DATA
* ARIX BIOSCIENCE PLC - AURA BIOSCIENCES REPORTS POSITIVE
PHASE
1B/2 CLINICAL DATA FOR AU-011
* ARIX BIOSCIENCE PLC - AURA SAYS ALL PATIENTS MET
PRELIMINARY
EFFICACY ENDPOINT TO DATE WITH EVIDENCE OF BIOLOGICAL ACTIVITY
* ARIX BIOSCIENCE PLC - AURA PLANS TO INITIATE A PIVOTAL
PHASE 3
CLINICAL STUDY
Source text for Eikon: ID:nPRrUF3A9a
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))